To foray in Mexican & Latin American markets
Lupin announced today the acquisition of 100% equity stake in Laboratorios Grin S.A. De C.V., Mexico, subject to certain closing conditions. The acquisition marks Lupin's foray into the high growth Mexican and the larger Latin American pharmaceuticals market.Powered by Capital Market - Live News
